Economic analysis of cancer treatment costs: another tool for oncology managers.
Oncology managers increasingly need more information about how much and why treatment costs vary across cancer patients. In response to this need, our Center is building an analytic capacity for investigating economic aspects of cancer treatment. Economic analysis is characterized by a simultaneous consideration of treatment costs and outcomes; it focuses on how treatment cost/outcome ratios vary across patient populations with similar diseases. In this paper, we present an overview of our work, with special emphasis on the measurement of outcomes and the inputs or costs of treatment, the variability of cost/outcome ratios, and the analysis of the factors that predict or explain this observed variation. We illustrate how the analysis is conducted, set out selected results relating to lung and breast cancer patients, and assess some of the advantages and disadvantages of the approach. Among other things, we conclude that economic analysis of cancer treatment costs is feasible and that it can provide useful data for managerial decision making.
Chirikos
T N
TN
H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, Tampa, USA.
Ruckdeschel
J C
JC
Krischer
J P
JP
D000368:Aged; D001943:Breast Neoplasms / Q000191:economics* / Q000628:therapy*; D002173:Cancer Care Facilities / Q000191:economics*; D003362:Cost-Benefit Analysis; D016208:Databases, Factual; D005260:Female; D017048:Health Care Costs; D017722:Hospital Charges; D006801:Humans; D008175:Lung Neoplasms / Q000191:economics* / Q000628:therapy*; D008329:Managed Care Programs; D008495:Medical Oncology / Q000191:economics*; D008875:Middle Aged; D017059:Models, Econometric; D015999:Multivariate Analysis; D019057:Quality-Adjusted Life Years; D016019:Survival Analysis; D014481:United States